Skip to main content
CADL logo

CADL

Candel Therapeutics, Inc.
$9.48 -0.16 (-1.66%) At close · Jul 16
Market Cap
$694.60M
Shares
73,270,239

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
Paul Peter Tak $5,344,561
Francesca Barone $1,561,536
Charles Schoch $1,470,817
Fiscal 2024
Executive Total
Paul Peter Tak $1,449,222
Francesca Barone $726,222
Seshu Tyagarajan $613,231
Fiscal 2023
Executive Total
Paul Peter Tak $1,484,759
Francesca Barone $706,876
Jason A. Amello $692,025
Fiscal 2022
Executive Total
Paul Peter Tak $1,844,971
Seshu Tyagarajan $916,020
Francesca Barone $908,302
Fiscal 2021
Executive Total
Paul Peter Tak $956,800
Estuardo Aguilar-Cordova $526,386
John Canepa $449,123
Francesca Barone $364,797
Seshu Tyagarajan
Fiscal 2020
Executive Total
Paul Peter Tak $2,626,511
John Canepa $1,319,316
Estuardo Aguilar-Cordova $740,153
Key facts CIK 1841387 CUSIP 137404109 13F (30d) 3 filings 3 filers Visit website Investor relations